​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $502.42, with a high of $843.00 and a low of $83.00. This represents a 70.87% increase from the last price of $294.04.

- $170 $340 $510 $680 $850 High: $843 Avg: $502.42 Low: $83 Last Closed Price: $294.04

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (80.00%), 2 Hold (13.33%), 1 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 15 0 1 2 12 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines70.87%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts21828
Avg Price Target$651.50$477.28$372.36
Last Closing Price$294.04$294.04$294.04
Upside/Downside121.57%62.32%26.64%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26212-1-15
Dec, 25212-1-15
Nov, 25310-1-14
Oct, 25310-1-14
Sep, 2538-1-12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 05, 2026Ami FadiaNeedham$460.00$286.4060.61%56.44%
Dec 29, 2025BTIG$843.00$268.95213.44%186.70%
Dec 15, 2025UBS$750.00$268.69179.13%155.07%
Dec 15, 2025Jay OlsonOppenheimer$750.00$268.69179.13%155.07%
Dec 12, 2025Deutsche Bank$313.00$272.0015.07%6.45%
Dec 09, 2025Jefferies$450.00$264.4070.20%53.04%
Dec 09, 2025Yatin SunejaGuggenheim$760.00$270.98180.46%158.47%
Dec 08, 2025Truist Financial$500.00$273.1183.08%70.04%
Dec 08, 2025Needham$315.00$247.9927.02%7.13%
Dec 08, 2025Kambiz YazdiBTIG$507.00$247.99104.44%72.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 12, 2026WedbushUnderperformUnderperformhold
Jan 05, 2026NeedhamBuyBuyhold
Jan 02, 2026Cowen & Co.BuyBuyhold
Dec 30, 2025CitigroupConviction BuyConviction Buyhold
Dec 30, 2025H.C. WainwrightBuyBuyhold
Dec 29, 2025GuggenheimBuyBuyhold
Dec 29, 2025BTIGBuyBuyhold
Dec 15, 2025OppenheimerOutperformOutperformhold
Dec 09, 2025JefferiesBuyBuyhold
Dec 09, 2025GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21----
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M----
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%----

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 15 Wall Street analysts, averages $502.42 over the next 12 months. The price target range spans from $83 at the low end to $843 at the high end, suggesting a potential 70.87% change from the previous closing price of $294.04.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 70.87% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • January 2026: 13.33% Strong Buy, 80.00% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.
  • December 2025: 13.33% Strong Buy, 80.00% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.
  • November 2025: 21.43% Strong Buy, 71.43% Buy, 0% Hold, 7.14% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2025 is $-11.47, marking a 12.34% increase from the reported $-10.21 in 2024. Estimates for the following years are $-11.46 in 2026, $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2025 is $967.3K, reflecting a -88.69% decrease from the reported $8.55M in 2024. The forecast for 2026 is $31.98M, followed by $101.46M for 2027, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2025 stands at $-75.239M, representing a -58.84% decrease from the reported $-183M in 2024. Projections indicate $-85.528M in 2026, $-66.138M in 2027, and $-15.629M in 2028.